BARBOLINI, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 2.010
EU - Europa 1.435
AS - Asia 358
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 6
AF - Africa 2
Totale 3.833
Nazione #
US - Stati Uniti d'America 1.990
IT - Italia 457
IE - Irlanda 324
GB - Regno Unito 221
SE - Svezia 129
CN - Cina 113
DE - Germania 96
HK - Hong Kong 73
FR - Francia 48
FI - Finlandia 33
TR - Turchia 33
IN - India 25
BG - Bulgaria 24
JP - Giappone 23
UA - Ucraina 23
ID - Indonesia 22
BE - Belgio 21
VN - Vietnam 20
CA - Canada 17
LT - Lituania 17
TW - Taiwan 16
MY - Malesia 13
BR - Brasile 9
EU - Europa 9
PL - Polonia 6
ES - Italia 5
MT - Malta 5
AL - Albania 4
AU - Australia 4
NL - Olanda 4
CR - Costa Rica 3
CZ - Repubblica Ceca 3
IR - Iran 3
RO - Romania 3
SA - Arabia Saudita 3
SG - Singapore 3
GR - Grecia 2
IQ - Iraq 2
KR - Corea 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
RU - Federazione Russa 2
AR - Argentina 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CO - Colombia 1
EC - Ecuador 1
ET - Etiopia 1
HR - Croazia 1
IL - Israele 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
ZM - Zambia 1
Totale 3.833
Città #
Chandler 325
Dublin 323
Fairfield 225
Ashburn 166
Southend 152
Woodbridge 118
Nyköping 114
Ann Arbor 101
Seattle 97
Wilmington 97
Cambridge 77
Houston 76
Hong Kong 70
Dearborn 63
New York 50
Modena 46
Beijing 41
Jacksonville 37
Fremont 34
Helsinki 32
Milan 30
San Diego 30
Redwood City 28
Princeton 25
Sofia 24
Bologna 23
Jakarta 22
Falls Church 20
San Giuliano Milanese 20
Dong Ket 19
Bremen 18
Brussels 18
Shanghai 18
Eugene 16
Rome 13
London 12
Paris 12
Parma 12
New Taipei 11
Reggio Emilia 11
Izmir 10
Caprarola 8
Tokyo 8
Norwalk 7
Santorso 7
Shinjuku 7
Venezia 7
Boardman 6
Castelvetrano 6
Des Moines 6
Guangzhou 6
Istanbul 6
Vernon 6
Aydin 5
Bomporto 5
Changchun 5
Los Angeles 5
Napoli 5
Padova 5
Sassuolo 5
Savona 5
Taipei 5
Toronto 5
Vicenza 5
Bagnara di Romagna 4
Carpi 4
Genoa 4
Kunming 4
Lüleburgaz 4
Mesagne 4
Ottawa 4
Palermo 4
Wandsworth 4
Amsterdam 3
Breganze 3
Brooklyn 3
Bussolengo 3
Chengdu 3
Chiswick 3
Coral Springs 3
Hefei 3
Kilburn 3
Maruggio 3
Monza 3
Mumbai 3
Phoenix 3
Presezzo 3
Rabat 3
San José 3
Sint-pieters-leeuw 3
Voghera 3
Acton 2
Aglientu 2
Arcola 2
Athens 2
Bangalore 2
Bari 2
Bedizzole 2
Brembate di Sopra 2
Calcinaia 2
Totale 2.879
Nome #
GD2 expression in breast cancer. 283
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 213
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 212
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus 212
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 198
A concise review of lenalidomide therapy for follicular lymphoma 179
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 179
Interstitial Lung Disease in Abemaciclib-treated Patients during SARS-CoV-2 Pandemic: A Case Series. 179
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer 174
The evolving role of microsatellite instability in colorectal cancer: A review 170
Breast Location for De Novo Extramedullary Myeloid Sarcoma 158
Primary and secondary prevention to effectively reduce the risk of bisphosphonate-related osteonecrosis of the jaw in patients with bone metastases . 146
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 142
Endocrine therapy alone versus targeted combination strategy as first line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trial 141
Impact of anaemia on tumor response to neoadjuvant chemotherapy in breast cancer patients . 125
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: To prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials 123
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 122
PROGNOSIS AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY ACCORDING TO HER2 EXPRESSION IN EARLY BREAST CANCER: a retrospective single institution analysis 117
Endocrine-based targeted combination versus endocrine therapy alone as first-line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trials. 110
LETTER TO THE EDITOR: Henoch-schönlein Purpura (HSP) in a Patient on Abemaciclib 105
Thromboembolism (TE) and adjuvant endocrine therapy (AET) in hormone receptor positive (HR+) early breast cancer (EBC): Did the evolution of treatment change the incidence of the adverse event? A metanalysis 102
Primary treatment strategy in elderly patients with hormone receptor positive early breast cancer: is breast cancer surgery. 100
TDM-1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: A meta-analysis 99
Predictors of HER2 gene amplification in immunohistochemistry score 2+ Early Breast Cancer according to 2018 ASCO/CAP guidelines: a single institution analysis. 78
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis. 63
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 45
Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review. 43
Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis 23
Adjuvant Endocrine Therapy in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer: Risk Stratification in a Real-World Setting 21
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients 14
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 9
Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-Analysis 3
Totale 3.888
Categoria #
all - tutte 14.373
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.373


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201949 0 0 0 0 0 0 0 0 0 0 0 49
2019/2020513 35 16 17 40 54 77 103 49 43 20 32 27
2020/2021638 61 64 42 80 88 60 19 60 33 44 36 51
2021/2022650 43 80 34 23 29 60 33 39 61 46 116 86
2022/20231.195 88 133 95 83 83 94 26 85 383 32 47 46
2023/2024621 31 36 63 66 61 57 80 63 35 36 66 27
Totale 3.888